Evidence map›Paper›PMID 18926834›Full record

ReviewMutation research2008

Linking Heterochromatin Protein 1 (HP1) to cancer progression.

George K Dialynas, Michael W Vitalini, Lori L Wallrath

Abstract readReview
In one paragraph

Review in Mutation research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 139 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Nerves in gastrointestinal cancer: from mechanism to modulations.Nature reviews. Gastroenterology & hepatology · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Interactions and Feedbacks in E-Cadherin Transcriptional Regulation.Frontiers in cell and developmental biology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

George K DialynasDepartment of Biochemistry, 3136 MERF, University of Iowa, Iowa City, IA 52242, USA.
Michael W Vitalini
Lori L Wallrath
University of Iowa · US

Funding

UPGRADE OF COMMUNICATIONS INFRASTRUCTURET34GM008574 · NIGMS · SAN FRANCISCO STATE UNIVERSITY · PI BAYLISS, FRANK T, ESQUERRA, RAYMOND M. · 1996 to 2021
$14.5M
Mechanisms of Gene SilencingR01GM061513 · NIGMS · UNIVERSITY OF IOWA · PI WALLRATH, LORI L · 2001 to 2009
$2.5M
NIGMS NIH HHS GM08574NIGMS NIH HHS GM61513NIGMS NIH HHS R01 GM061513NIGMS NIH HHS T34 GM008574
6 · The paper itself

Abstract

All cells of a given organism contain nearly identical genetic information, yet tissues display unique gene expression profiles. This specificity is in part due to transcriptional control by epigenetic mechanisms that involve post-translational modifications of histones. These modifications affect the folding of the chromatin fiber and serve as binding sites for non-histone chromosomal proteins. Here we discuss functions of the Heterochromatin Protein 1 (HP1) family of proteins that recognize H3K9me, an epigenetic mark generated by the histone methyltransferases SU(VAR)3-9 and orthologues. Loss of HP1 proteins causes chromosome segregation defects and lethality in some organisms; a reduction in levels of HP1 family members is associated with cancer progression in humans. These consequences are likely due to the role of HP1 in centromere stability, telomere capping and the regulation of euchromatic and heterochromatic gene expression.

Indexed as

AnimalsCentromereChromatinChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneDisease ProgressionGene Expression RegulationHeterochromatinHumansModels, GeneticNeoplasmsTelomereVirusesChromatinChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHeterochromatin

Identifiers

PMID18926834
PMCPMC2637788
OpenAlexW2066251436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.